LGC AccuPlex SARS-CoV-2 Reference Material

Products are for professional/laboratory use only.  In response to the severe threat to public health posed by the global spread of COVID-19, LGC SeraCare has developed reference materials utilizing their proprietary AccuPlex technology. These will serve as valuable tools to accelerate development, validation, and implementation of precision diagnostic tests necessary to ensure accurate diagnosis of COVID-19.

LGC’s SARS-CoV-2 AccuPlex Solution:

• Non-infectious and replication deficient, enables safe handling of positive material
• Fully-extractable with a real viral protein coat; serves as a full-process control
• Compatible with assays targeting CDC and WHO consensus sequences
• Optimal solution for initial assay installation and verification
• Challenges assay performance across entire assay range
• Includes negative reference material for targeting sequences for the human RNAse P gene
• 2 year stability at 2 – 8°C

AccuPlex™ SARS-CoV-2 Reference Material

AccuPlex SARS-CoV-2 Reference Material is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution.

AccuPlex SARS-CoV-2 Verification Panel

AccuPlex SARS-CoV-2 Verification Panel is optimized for assay verification at installation by documenting test performance along the assay’s range enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency.

Go Back